Royal DSM  has completed the creation of a 75/25 joint venture (JV) with Nenter & Co., Inc., as first announced on 29 January 2019. The JV acquired all Nenter’s Jingzhou Vitamin E production and related assets. The JV will immediately start implementing the anticipated upgrade activities to ensure compliance with DSM’s safety, health and environmental standards, and will therefore stop production. The shutdown will last as long as needed to finalize these significant upgrades.

The JV now owns and will operate the vitamin E production facilities in Jingzhou, Hubei, China and has a minority shareholding in Nenter’s Shishou facility, in Hubei, China, where an intermediate for vitamin E is produced. The JV will produce vitamin E exclusively for DSM.

The JV will upgrade and refurbish the facilities to secure a high-quality and sustainable supply of vitamin E, which complies with DSM’s safety, health and environmental standards.

The shutdown that was already planned as from beginning of September will be extended to enable the implementation of these upgrade activities.